Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$50,463
-$11,553 QoQ
Shares Held
322
-20.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,429
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cassaday & Co Wealth Management LLC holds $26,780,634 across 15 Drug Manufacturers - General names. NVS ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
33,482 | $8,503,423 | |
| 2 | LLY |
ELI LILLY & Co
|
5,368 | $6,438,540 | |
| 3 | ABBV |
AbbVie Inc.
|
20,820 | $5,239,144 | |
| 4 | MRK |
Merck & Co., Inc.
|
28,760 | $3,695,660 | |
| 5 | AMGN |
Amgen Inc
|
3,642 | $1,318,841 | |
| 6 | PFE |
Pfizer Inc
|
29,619 | $713,225 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,439 | $486,255 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
972 | $122,802 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,463 | 322 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $62,016 | 406 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||